Literature DB >> 21859610

A multiscale model of atherosclerotic plaque formation at its early stage.

Giulia Di Tomaso1, Vanessa Díaz-Zuccarini, Cesar Pichardo-Almarza.   

Abstract

A multiscale model of atherosclerotic plaque formation at its early stage has been developed in order to integrate the various phenomena leading to fatty streak formation. The different scales considered in this model are in both the spatial domain (from cellular to organism level) and the time domain (from seconds to months). The cellular level was considered by modeling the transport and chemical interactions of low-density lipoproteins (LDL) and other agents in a stenosed artery. This was linked to arterial thickening (organ level). Mean blood LDL level (organism level) was selected as one of the critical factors for atherosclerotic formation along with wall shear stress (WSS) exerted on the endothelium (the inner portion of the artery). It was observed that plaque location was dependent on WSS and that plaque size, number, and growth was dependent on mean blood LDL levels as well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859610     DOI: 10.1109/TBME.2011.2165066

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  6 in total

1.  WELL-POSEDNESS OF A MATHEMATICAL MODEL OF DIABETIC ATHEROSCLEROSIS WITH ADVANCED GLYCATION END-PRODUCTS.

Authors:  Xuming Xie
Journal:  Appl Anal       Date:  2022-04-06       Impact factor: 1.278

2.  Mathematical modelling of atheroma plaque formation and development in coronary arteries.

Authors:  Myriam Cilla; Estefanía Peña; Miguel A Martínez
Journal:  J R Soc Interface       Date:  2013-11-06       Impact factor: 4.118

3.  Understanding the Effect of Statins and Patient Adherence in Atherosclerosis via a Quantitative Systems Pharmacology Model Using a Novel, Hybrid, and Multi-Scale Approach.

Authors:  Cesar Pichardo-Almarza; Vanessa Diaz-Zuccarini
Journal:  Front Pharmacol       Date:  2017-09-13       Impact factor: 5.810

4.  A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics.

Authors:  Jeffrey E Ming; Ruth E Abrams; Derek W Bartlett; Mengdi Tao; Tu Nguyen; Howard Surks; Katherine Kudrycki; Ananth Kadambi; Christina M Friedrich; Nassim Djebli; Britta Goebel; Alex Koszycki; Meera Varshnaya; Joseph Elassal; Poulabi Banerjee; William J Sasiela; Michael J Reed; Jeffrey S Barrett; Karim Azer
Journal:  Gene Regul Syst Bio       Date:  2017-06-22

5.  Using a Systems Pharmacology Approach to Study the Effect of Statins on the Early Stage of Atherosclerosis in Humans.

Authors:  C Pichardo-Almarza; L Metcalf; A Finkelstein; V Diaz-Zuccarini
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-12-30

6.  Towards personalised management of atherosclerosis via computational models in vascular clinics: technology based on patient-specific simulation approach.

Authors:  Vanessa Díaz-Zuccarini; Giulia Di Tomaso; Obiekezie Agu; Cesar Pichardo-Almarza
Journal:  Healthc Technol Lett       Date:  2014-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.